Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015 (2015), Article ID 857108, 8 pages
http://dx.doi.org/10.1155/2015/857108
Research Article

First-Trimester Serum Acylcarnitine Levels to Predict Preeclampsia: A Metabolomics Approach

1Department of Obstetrics, Wilhelmina Children’s Hospital, University Medical Centre Utrecht (UMCU), 3508 AB Utrecht, Netherlands
2Leiden Academic Centre for Drug Research, Division of Analytical Biosciences, Leiden University, 2300 RA Leiden, Netherlands
3Discovery & Exploratory BA, Pharmacokinetics, Dynamics & Metabolism, Discovery Sciences, Janssen Pharmaceutica, Beerse, Belgium
4Centre for Infectious Diseases Research, Diagnostics and Screening (IDS), National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, Netherlands
5Netherlands Metabolomics Centre, 3501 DE Utrecht, Netherlands
6Centre for Health Protection (GZB), National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, Netherlands

Received 13 April 2015; Accepted 27 May 2015

Academic Editor: Vincent Sapin

Copyright © 2015 Maria P. H. Koster et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Maria P. H. Koster, Rob J. Vreeken, Amy C. Harms, et al., “First-Trimester Serum Acylcarnitine Levels to Predict Preeclampsia: A Metabolomics Approach,” Disease Markers, vol. 2015, Article ID 857108, 8 pages, 2015. doi:10.1155/2015/857108